128 related articles for article (PubMed ID: 7176218)
1. In vitro metabolism of sulindac and sulindac sulfide: enzymatic formation of sulfoxide and sulfone.
Kitamura S; Tatsumi K
Jpn J Pharmacol; 1982 Oct; 32(5):833-8. PubMed ID: 7176218
[TBL] [Abstract][Full Text] [Related]
2. Metabolism in vitro of sulindac. Sulfoxide-reducing enzyme systems in guinea pig liver.
Kitamura S; Tatsumi K; Yoshimura H
J Pharmacobiodyn; 1980 Jun; 3(6):290-8. PubMed ID: 6775073
[TBL] [Abstract][Full Text] [Related]
3. Renal metabolism of sulindac: functional implications.
Miller MJ; Bednar MM; McGiff JC
J Pharmacol Exp Ther; 1984 Nov; 231(2):449-56. PubMed ID: 6436473
[TBL] [Abstract][Full Text] [Related]
4. Stereoselective sulfoxidation of sulindac sulfide by flavin-containing monooxygenases. Comparison of human liver and kidney microsomes and mammalian enzymes.
Hamman MA; Haehner-Daniels BD; Wrighton SA; Rettie AE; Hall SD
Biochem Pharmacol; 2000 Jul; 60(1):7-17. PubMed ID: 10807940
[TBL] [Abstract][Full Text] [Related]
5. Sulfoxide reduction. In vitro reduction of sulindac by rat hepatic cytosolic enzymes.
Ratnayake JH; Hanna PE; Anders MW; Duggan DE
Drug Metab Dispos; 1981; 9(2):85-7. PubMed ID: 6113122
[TBL] [Abstract][Full Text] [Related]
6. Effect of dimethyl sulfoxide on sulindac disposition in rats.
Swanson BN; Mojaverian P; Boppana VK; Dudash MR
Drug Metab Dispos; 1981; 9(6):499-502. PubMed ID: 6120805
[TBL] [Abstract][Full Text] [Related]
7. Thioredoxin-dependent sulfoxide reduction by rat renal cytosol.
Anders MW; Ratnayake JH; Hanna PE; Fuchs JA
Drug Metab Dispos; 1981; 9(4):307-10. PubMed ID: 6114827
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of sulindac metabolism by dimethyl sulfoxide in the rat.
Swanson BN; Mojaverian P; Boppana VK
J Toxicol Environ Health; 1983; 12(2-3):213-22. PubMed ID: 6655731
[TBL] [Abstract][Full Text] [Related]
9. Effect of uremia and anephric state on the pharmacokinetics of sulindac and its metabolites in rats. I. An application of pharmacokinetic model for reversible metabolism.
Lin JH; Yeh KC; Duggan DE
Drug Metab Dispos; 1985; 13(5):602-7. PubMed ID: 2865111
[TBL] [Abstract][Full Text] [Related]
10. Identification of the biologically active form of sulindac.
Duggan DE; Hooke KF; Risley EA; Shen TY; Arman CG
J Pharmacol Exp Ther; 1977 Apr; 201(1):8-13. PubMed ID: 850147
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of the tissue distributions of sulindac and metabolites. Relevance to sites and rates of bioactivation.
Duggan DE; Hooke KF; Hwang SS
Drug Metab Dispos; 1980; 8(4):241-6. PubMed ID: 6105058
[TBL] [Abstract][Full Text] [Related]
12. Reduction of Sulindac to its active metabolite, sulindac sulfide: assay and role of the methionine sulfoxide reductase system.
Etienne F; Resnick L; Sagher D; Brot N; Weissbach H
Biochem Biophys Res Commun; 2003 Dec; 312(4):1005-10. PubMed ID: 14651971
[TBL] [Abstract][Full Text] [Related]
13. Comparative disposition of sulindac and metabolites in five species.
Duggan DE; Hooke KF; Noll RM; Hucker HB; Van Arman CG
Biochem Pharmacol; 1978; 27(19):2311-20. PubMed ID: 103551
[No Abstract] [Full Text] [Related]
14. Biotransformation of sulindac in end-stage renal disease.
Gibson TP; Dobrinska MR; Lin JH; Entwistle LA; Davies RO
Clin Pharmacol Ther; 1987 Jul; 42(1):82-8. PubMed ID: 3595070
[TBL] [Abstract][Full Text] [Related]
15. Dimethyl sulfoxide inhibits bioactivation of sulindac.
Swanson BN; Boppana VK; Vlasses PH; Rotmensch HH; Ferguson RK
J Lab Clin Med; 1983 Jul; 102(1):95-101. PubMed ID: 6854139
[TBL] [Abstract][Full Text] [Related]
16. Effect of uremia and anephric state on the pharmacokinetics of sulindac and its metabolites in rats. II. Differential effects on the biliary excretion.
Lin JH; Yeh KC; Duggan DE
Drug Metab Dispos; 1985; 13(5):608-13. PubMed ID: 2865112
[TBL] [Abstract][Full Text] [Related]
17. Studies on the chirality of sulfoxidation catalyzed by bacterial flavoenzyme cyclohexanone monooxygenase and hog liver flavin adenine dinucleotide containing monooxygenase.
Light DR; Waxman DJ; Walsh C
Biochemistry; 1982 May; 21(10):2490-8. PubMed ID: 7093199
[TBL] [Abstract][Full Text] [Related]
18. Sulindac: therapeutic implications of the prodrug/pharmacophore equilibrium.
Duggan DE
Drug Metab Rev; 1981; 12(2):325-37. PubMed ID: 7040018
[TBL] [Abstract][Full Text] [Related]
19. Sulphoxide reduction by rat and rabbit tissues in vitro.
Lee SC; Renwick AG
Biochem Pharmacol; 1995 May; 49(11):1557-65. PubMed ID: 7786296
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of sulindac with other cyclooxygenase inhibitors on prostaglandin excretion and renal function in normal and chronic bile duct-ligated dogs and swine.
Zambraski EJ; Chremos AN; Dunn MJ
J Pharmacol Exp Ther; 1984 Mar; 228(3):560-6. PubMed ID: 6423807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
